Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
It suppresses post-meal glucagon secretion
step 1 See your whole patient at a glance Labs, wearables, current supplements, and patient history together in one clear view
We call them chronic care for chronic disease
Head-to-Head Superiority (SURMOUNT-5): The SURMOUNT-5 trial, with detailed results published in The New England Journal of Medicine on May 11, 2025, directly compared Tirzepatide (Zepbound) with semaglutide (Wegovy)
What Patients Should Discuss with Their Doctor Patients should discuss confirmed liver disease status, FIB-4 fibrosis risk score, metabolic comorbidities, and clinical trial eligibility with their GP or specialist before drawing conclusions about retatrutide's relevance to their care
US$ 21.61
US$ 22.92
US$ 20.38
US$ 21.13
